Back to Top Skip to main content

World AIDS Day puts spotlight on landmark DoD study

Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo) Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration. (U.S. Army photo)

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

The Walter Reed Army Institute of Research (WRAIR) hosted a World AIDS Day event Tuesday, Nov. 26, highlighting advances in DoD-led HIV research and celebrating the 10th anniversary of the Army-led RV144 HIV vaccine study.

WRAIR’s Military HIV Research Program or MHRP headed the RV144 study, the first-ever – and only to-date – clinical trial to demonstrate that an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The study sought to determine what methods could be used to lower risk of contracting the disease.

The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration. It involved more than 16,000 adult volunteers and a large network of partners who still work with WRAIR today, including the Thai Ministry of Public Health; the National Institute of Allergy and Infectious Diseases – part of the National Institutes of Health; and Sanofi Pasteur.

In 2009, the Army announced that the study’s investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, although modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.

“RV144 was the light at the time in the field, without which we may have given up,” said Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center and the featured speaker at WRAIR’s World AIDS Day event. “In the last 10 years of HIV vaccine progress, RV144 is the anchor.”

The landmark trial continues to provide scientific direction to help guide vaccine development and testing. RV144 and its follow-on trials allowed researchers to discover of risk factors, provide targets for optimizing vaccine boosting, and form a foundation for three HIV vaccine candidates currently undergoing efficacy testing. A video featuring many prominent HIV researchers who were involved with RV144 was shown at the World AIDS Day event.

Also at the event, Lt. Gen (Ret.) Eric B. Schoomaker, 42nd surgeon general of the United States Army and former commanding general of the United States Army Medical Command, highlighted the military’s earliest contributions to HIV research, which include the development of a disease staging system and promoting the finding that HIV can be transmitted heterosexually. The military’s HIV research efforts were consolidated in 1986 with the establishment of MHRP.

MHRP’s initial mission was to advance an HIV vaccine to protect service members and the global community from HIV, but has since expanded beyond vaccine development to include cure research and prevention and treatment services in Africa under the President’s Emergency Plan for AIDS Relief or PEPFAR. Via PEPFAR initiatives, WRAIR provides life-saving antiretroviral therapy to more than 350,000 people living with HIV in sub-Saharan Africa, which contributes to global health security.

WRAIR supports PEPFAR activities within military and civilian communities in four countries where it conducts research (Nigeria, Tanzania, Uganda, and Kenya), which strengthens community trust and provides an ethical framework for clinical studies. The Department of Defense HIV/AIDS Prevention Program, led by the U.S. Navy, is responsible for assisting foreign military partners with the development and implementation of military-specific HIV/AIDS prevention and treatment programs in more than 55 countries around the globe, also supported by PEPFAR.

“Those countries that partner with us on PEPFAR have a 40-percent decrease in violence and a 40-increase in political stability,” said WRAIR Commander Army Col. Deydre Teyhen. “So we say that soldier health is world health. But in fighting HIV/AIDS, WRAIR researchers are also working to advance world peace.”

More information can be found on the RV144 HIV Trial web page.

You also may be interested in...

NAMRU-SA partakes in virtual San Antonio postdoctoral research forum

Article
1/19/2021
Military officer sitting at her desk and smiling

For NAMRU-SA it was an opportunity to highlight the unit’s battlefield health and trauma care initiatives.

Recommended Content:

Research and Innovation

Immunization Tool Kit 9th Edition

Publication
1/14/2021

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. The Defense Health Agency Immunization Healthcare Division (DHA-IHD) publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines.

Recommended Content:

Immunization Healthcare

Joint Warfighter Medical Research Program

Congressional Testimony
1/11/2021

S. 3159, SAC Report for FY 2019 , 115-290 , Pg. 210

Recommended Content:

Research and Innovation

MHS operational innovations continue in battle against COVID-19

Article
1/5/2021
Two medical personnel, wearing full PPE, in an operating room

MHS innovations in 2020 include a new registry for real-time COVID-19 data and a system to free up hospital beds and protect patients from the disease.

Recommended Content:

Coronavirus | Research and Innovation | Innovation | Technology

DHA’s IT innovation continues during COVID-19 pandemic

Article
12/31/2020
Three military personnel, wearing masks, in front of a computer screen

IT innovations keep pace despite COVID-19 road blocks.

Recommended Content:

Coronavirus | Research and Innovation | Technology | MHS GENESIS

Recommendations for Mass Immunization Events During Pandemic Conditions

Fact Sheet
12/28/2020

During pandemic conditions, planners of mass immunization events need to consider additional measures to minimize risk of COVID-19 or similar infectious disease transmission.

Recommended Content:

Immunization Healthcare

AFHSD’s GEIS collect data worldwide to support force protection

Article
12/22/2020
Medical personnel scanning forehead of soldier with thermometer

AFHSD/GEIS continue work with partners across the globe in their efforts to combat COVID-19 and protect military readiness.

Recommended Content:

Health Readiness | Public Health | Coronavirus | Biological Surveillance Tools | Global Health Engagement | Armed Forces Health Surveillance Branch | COVID-19 Vaccine Efforts

MHS Team Resiliency Awards recognize medical response to COVID-19

Article
12/22/2020
Sailors wearing masks, leaning on a table and writing on sheets of paper

Outstanding efforts recognized during Resiliency Awards

Recommended Content:

Coronavirus | Research and Innovation

Nurse-led research aims to improve battlefield medicine

Article
12/21/2020
Military nurses working on a simulated patient in a helicopter

[O]ne of their goals is to create novel solutions to optimize survival and functional recovery of burn casualties.

Recommended Content:

Combat Support | Research and Innovation

COVID-19 Vaccine Update | How Vaccines are Developed

Video
12/14/2020
COVID-19 Vaccine Update | How Vaccines are Developed

COVID-19 vaccines are within sight in the United States! Scientists continue making progress in testing and monitoring COVID-19 vaccines for safety and effectiveness, and the federal government is ensuring that all adults who want a vaccine will be able to get one at no cost. Learn how these and other vaccines are developed, tested, and authorized for use – and how they work to prevent diseases like COVID-19. This video uses interviews and visuals to help viewers understand the science behind vaccines and why there is reason for optimism. Experts featured in the video include: Dr. Anthony Fauci, National Institutes of Health; Dr, Moncef Slaoui, Operation Warp Speed; Dr. Stephen Hahn, Food and Drug Administration; Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response in the Department of Health and Human Services. For more information, visit http://www.coronavirus.gov.

Recommended Content:

COVID-19 Vaccine Efforts | Immunization Healthcare

USAMRIID scientist recognized by French for distinguished service

Article
12/4/2020
Two military officers on stage; one handing the other a certificate

Kugelman...identified genetic markers of persistence of the Chikungunya virus.

Recommended Content:

Health Readiness | Research and Innovation | Technology

METC improves surgical tech training with new laparoscopy standard

Article
12/1/2020
Surgical team in operating room

A laparoscopy is a low-risk, non-invasive surgical procedure used to examine organs inside the abdomen and repair or remove tissue.

Recommended Content:

Combat Support | Health Readiness | Research and Innovation | Technology

Forging of civil-military anvil against COVID-19 focus at GHSA

Article
11/9/2020
U.S. and Thai soldiers stand together during a medical exercise.

“Defense partnerships around the world are key.”

Recommended Content:

Coronavirus | Global Health Engagement | Health Readiness | Global Health Engagement

Walter Reed, VA focus on joint efforts in 3D medical application

Article
11/9/2020
Three physicians wearing masks; one sitting at a desk, two standing

The JIF award focuses on the Department of Defense/VA 3D Printing Consortium for Medical Applications.

Recommended Content:

Research and Innovation | Technology

BAMC, Argentine Army medical providers share COVID-19 best practices

Article
11/4/2020
Video teleconference image

U.S. Army South facilitated the virtual subject matter expert (SME) exchange between BAMC and CMMH.

Recommended Content:

Coronavirus | Global Health Engagement | Technology | COVID-19 Vaccine Efforts | Public Health | Convalescent Plasma Collection Program
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 18

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.